SF3B1 and myelodysplastic syndrome: SF3B1 mutations mainly alter 3′ splice site selection through the recognition of cryptic branch points, leading to hundreds of novel alternative/aberrant transcripts [93] whose contribution in the MDS pathogenesis is still poorly understood.